The prevalence of liver steatosis was higher in people living with HIV compared with liver fibrosis, although both liver ...

In the wake of an unfavorable advisory committee meeting in September, Intercept Pharmaceuticals’ bid to win full approval ...

Rates of heavy drinking and of alcohol-related liver disease had been rising steadily for decades ... at levels defined as ...

Good morning, and welcome to the Wave Life Sciences Third Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen only mode. As a reminder, this call is being ...

Kumar, P. (2024). Serum zinc level in liver cirrhosis with hepatic encephalopathy and its correlation with different stages ...

Research and Development (R&D) Expenses: R&D expenses were $16.0 million for the three months ended September 30, 2024, as compared to $14.0 million for the same period in 2023. The increase was ...

The company previously said it believes Chinese authorities are probing allegations that employees illegally imported ...

The study notes that PFAS have been associated with a range of adverse health effects, including liver disease, cardiometabolic and cardiovascular ... on PFAS concentrations in prenatal plasma (6 to ...

The U.S. Food and Drug Administration on Tuesday declined full approval for Intercept Pharmaceuticals' liver disease drug, ...

Turmeric is a natural herb that may affect how well other medications and supplements work. This includes cancer medications ...

Capsida Biotherapeutics ("Capsida") today announced new preclinical data for CAP-004, a potential best-in-class systemically ...